Signals · rwdtx.com

What just happened at Rewind Therapeutics

Last updated 2026-10-06

Rewind Therapeutics secures additional financing to advance its oral GPR17 remyelination program. This funding will help complete key IND-enabling studies and support the clinical development of the therapy on 2026-10-06. It was reported by globenewswire.com.

The evidence, dated and sourced

1. 2026-10-06 — Funding: Rewind Therapeutics secures additional financing to advance its oral GPR17 remyelination program. This funding will help complete key IND-enabling studies and support the clinical development of the therapy.
   Press / news →

How this is sourced

Every row above links to the document it came from — an SEC filing on EDGAR, or the announcement a publisher ran. Fundz does not paraphrase a source it has not stored, and each row is labelled sec_filing or press_or_news so you can see which you are reading. Funding rounds come from SEC Form D filings and announcements; 8-K events come from the filings themselves. No contact or people data appears here.

Companies with recent events

• Expanse — last event 2026-09-16
• Brainomix — last event 2026-02-24
• Anfield Energy — last event 2026-07-30

Get this via API or MCP

The same evidence, as JSON, for your own agents. Quickstart → · MCP endpoint https://api.fundz.net/v1/agent/mcp

curl -s -X POST https://api.fundz.net/v1/agent/why_now \
  -H "X-Fundz-Key: $FUNDZ_KEY" -H "Content-Type: application/json" \
  -d '{"domain": "rwdtx.com"}'